Florida Bans Minors From Receiving Puberty Blockers And Reassignment Surgeries

Once again the Sunshine State of Florida showed the rest of the nation how to deal with radical social justice agenda items, this time trans issues in under-aged youth.

The Florida Board of Medicine and the Florida Board of Osteopathic Medicine Joint Rules/Legislative Committee voted to prohibit trans-identified minors from receiving puberty blockers, cross-sex hormones, and surgery on Friday.

The committee held a public meeting on the efficacy of pediatric “gender-affirming” care Friday in Orlando.

During the time for public comments, several former trans-identifying adults spoke of their negative experiences with “gender-affirming” care, including Chloe Cole, Cat Cattison, Helena Kerschner, Zoe Hawes, Camille Kiefel, Billy Burleigh, Ted Halley, Rachel Foster, and a male who goes by “Shapeshifter.”

Cole, an 18-year-old de-transitioned woman, gave the testimony of her experience with puberty blockers and testosterone at 13, and a double mastectomy surgery to remove her breasts at 15.

“Why is a mental health epidemic not being addressed with mental health treatment to get at the root causes for why female adolescents like me want to reject their bodies?” Cole asked.

“I have bandages on my chest today, over two years post-op, because my nipples leak fluid and they stain my clothes,” Cole testified.

“I have no breasts. I want to be a mother someday and yet I can never naturally feed my future children” Cole added.

Florida Board of Medicine Member Nicholas Romanello proposed the rule, describing how the risks of the treatments outweigh the benefits.

“I believe that based upon the testimony that we’ve heard this morning and the materials in the portal, that the risk of puberty suppressing therapies, cross-hormonal therapy, and surgery, those risks outweigh the possible benefits and that there is a lack of consistent, reliable, scientific peer-reviewed evidence concerning the efficacy and safety of such treatment,” Romanello said.

The board’s concerns are similar to those researched by the national health departments of SwedenFinland, and England. After reviewing all the available evidence, the three nations’ abandoned “gender-affirming” care.

Those who need the medications for other conditions will not be affected by this decision, according to Daily Mail.

The board is expected to make a decision on the effective date next week.

Get More Information HERE >>>

Sponsors

PureTalk – Save Big Money On Your Cell Phone Bill  (Use Promo”FLSfree” to get one free month)

MYPILLOW – Save Up To 66% On MyPillow Products – Use Promo Code – FTR  

Leave a Reply

Your email address will not be published. Required fields are marked *

Stories You Might Have Missed

Subscribe To Our Newsletter

[mc4wp_form id="69"]